Drug intelligence / Profile preview

Rowatinex

Development stage
Unknown
Lead developer
Rowa
Modality
Small Molecules
Administration
Oral
01

Overview

Rowatinex is a phytotherapeutic preparation containing a specific combination of monoterpenes, including alpha-pinene, beta-pinene, camphene, borneol, anethole, fenchone, and cineol. It is primarily indicated for the management of urolithiasis (urinary stones) and as an adjunct in medical expulsive therapy (MET) to facilitate the passage of stone fragments following extracorporeal shock-wave lithotripsy (ESWL). Rowatinex exerts its therapeutic effect through several pharmacological actions: it serves as an antispasmodic by relaxing ureteral smooth muscle, which reduces renal colic pain and promotes stone migration; it acts as a mild diuretic to increase urine flow and aid expulsion; and it provides anti-inflammatory and antibacterial effects to protect the urinary mucosa. Furthermore, it has been shown to stabilize urine pH and increase the solubility of calcium salts, thereby assisting in the prevention of stone recurrence (metaphylaxis).

Brand names
Rowatinex
Other names
terpene combinationterpene mixture

Beyond the preview

Go deeper on Rowatinex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rowatinex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call